Summit Therapeutics is a biopharmaceutical oncology company developing therapies for serious unmet medical needs. Headquartered in Miami with offices in California, New Jersey, the UK, and Ireland, we are a team of world-class professionals driven by integrity, passion, urgency, and collaboration.
Lead new indication strategy and planning across oncology indications, working cross-functionally to guide late-stage clinical development strategy.
Deliver strategic market and competitive intelligence insights through research, scenario planning, and impact assessments to guide executive decision-making.
Develop NPV, forecasting, and revenue modeling for new indications up to 18 months before launch, providing data-driven assumptions for early commercial planning.